High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines
- 1 July 1991
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 91 (1), 23-29
- https://doi.org/10.1016/0002-9343(91)90069-a
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 1990
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989
- Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized TrialThe Journal of Infectious Diseases, 1988
- Multiple actions of interleukin 6 within a cytokine networkImmunology Today, 1988
- Monocyte-Derived Human B-Cell Growth Factor Identified as Interferon-β 2 (BSF-2, IL-6)Science, 1988
- Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts.The Journal of Experimental Medicine, 1987
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferationCell, 1986
- Heterogeneity of poly(I).poly(C)-induced human fibroblast interferon mRNA speciesNature, 1980